ARTICLE | Company News
Zealand Pharma, Aventis deal
January 4, 2016 8:00 AM UTC
Zealand Pharma received a $20 million milestone payment from Aventis, now Sanofi (Euronext:SAN; NYSE:SNY, Paris, France), under a 2003 deal granting the pharma rights to LixiLan. The milestone was t...